Stem cell startup Aldagen earns CEO Cancer ‘Gold Standard’
Get the latest news alerts: Follow LTW at Twitter. CARY, N.C. – Aldagen , a startup focused on stem cell therapies and technology, is the latest company to receive accreditation from the CEO Roundtable on Cancer.
[Read the full article here]Related News:
Stem cell startup Aldagen raising $10 million, refiles plans for IPO
TechTown Startup Wins $200k For Stem Cell Tech …
Stem cell therapy maker Aldagen files for IPO